The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace ... results in severe metabolic disease, diabetes, insulin resistance and reduced life expectancy.

Type 2 diabetes medications include ... incretin mimetics are injectable medications that stimulate the production of insulin. They also slow the rate of digestion so that glucose enters the ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes ... release more insulin, bringing blood sugar down further, Tenpas explained. Older GLP-1 medications ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...